NCT07425054
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07425054
Title ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer (CHART-AC)
Acronym CHART-AC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jennifer Dorth
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.